A Dallas development firm is placing bets on the Pacific Northwest's fast-growing biotech sector after acquiring a downtown Seattle development site slated for a new life science office project.
A Dallas development firm is placing bets on the Pacific Northwest's fast-growing biotech sector after acquiring a downtown Seattle development site slated for a new life science office project.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In